Dabur India inks pact with government to produce two new ayurvedic drugs

25 Feb 2016 Evaluate

Dabur India has signed a licence pact with the government to produce two new ayurvedic drugs -- Ayush - 64 for treatment of malaria and Ayush- 82 for management of diabetes. The company is planning to commercially produce the two drugs within six months and they will be available in various formats.

The company has also signed a memorandum of understanding (MoU) with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, for collaboration and cooperation in the pharmaceutical R&D for different novel dosage forms and drug development in ayurveda. The ayurvedic formulations for both medicines were developed by CCRAS.

Dabur India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.

Dabur India Share Price

509.80 1.75 (0.34%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2339.00
Godrej Consumer Prod 1135.80
Dabur India 509.80
Colgate Palmol. (I) 2164.75
P&G Hygiene 12583.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×